Abstract
Streptococcus pyogenes is an important human pathogen that can cause a variety of diseases in immunocompetent individuals ranging from uncomplicated superficial infections to severe life-threatening infections including rapidly progressing deep tissue infections, such as necrotizing fasciitis (NF) and severe cellulitis. The pathogenesis of these infections is complex and multifactorial involving numerous virulence factors expressed by the bacteria. Here, we review data from epidemiologic, pathogenomic, and pathogenesis studies that have provided insight into the host–pathogen interactions that contribute to S. pyogenes tissue infections. The role of tissue-specific streptococcal types, intracellular bacterial persistence, and other immune evasion strategies resulting in massive bacterial load at the tissue site, as well as virulence factors contributing to a local hyperinflammatory response are highlighted. A particular focus is on in vivo findings in patients that provide insight into host and bacterial factors that are expressed at the infected tissue site, and the mechanisms underlying tissue pathology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andersson J, Nagy S, Björk L, Abrams J, Holm S, Andersson U (1992) Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol Rev 127:69–96
Aziz RK, Kotb M (2008) Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis 14:1511–1517
Basma H, Norrby-Teglund A, Guedez Y, McGeer A, Low DE, El-Ahmedy O, Schwartz B, Kotb M (1999) Risk factors in the pathogenesis of invasive group A streptococcal infections: Role of protective humoral immunity. Infect Immun 67:1871–1877
Beres SB, Richter EW, Nagiec MJ, Sumby P, Porcella SF, DeLeo FR, Musser JM (2006) Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci USA 103:7059–7064
Bessen DE, Sotir CM, Readdy TL, Hollingshead SK (1996) Genetic corrrelates of throat and skin isolates of group A streptococci. J Infect Dis 173:896–900
Bisno AL, Stevens DL (1996) Streptococcal infections of skin and soft tissues. N Engl J Med 334:240–245
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535
Bryant AE, Bayer CR, Huntington JD, Stevens DL (2006) Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. J Infect Dis 193:1685–1692
Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, Kotb M et al (2006) DNase expression allows the pathogen group A streptococcus to escape killing in neutrophil extracellular traps. Curr Biol 16: 396–400
Burns EH, Marciel AM, Musser JM (1996) Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect Immun 64:4744–4750
Carroll RK, Musser JM (2011) From transcription to activation: how group A streptococcus, the flesh-eating pathogen, regulates SpeB cysteine protease production. Mol Microbiol 81:588–601
Cederlund A, Gudmundsson GH, Agerberth B (2011) Antimicrobial peptides important in innate immunity. FEBS J 278:3942–3951
Chang A, Khemlani A, Kang H, Proft T (2011) Functional analysis of Streptococcus pyogenes nuclease A (SpnA), a novel group A streptococcal virulence factor. Mol Microbiol 79:1629–1642
Cole JN, Barnett TC, Nizet V, Walker MJ (2011) Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 9:724–736
Cole JN, McArthur JD, McKay FC, Sanderson-Smith ML, Cork AJ, Ranson M, Rohde M, Itzek A, Sun H, Ginsburg D, Kotb M, Nizet V, Chhatwal GS, Walker MJ (2006) Trigger for group A streptococcal M1T1 invasive disease. FASEB 20:E1139–E1145
Collin M, Olsén A (2001) Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 69:7187–7189
Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470–511
Davies DH, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE (1996) The Ontario group A streptococcal study group Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 135:547–554
Fittipaldi N, Beres SB, Olsen RJ, Kapur V, Shea PR, Watkins ME, Cantu CC, Laucirica DR, Jenkins L, Flores AR, Lovgren M, Ardanuy C, Liñares J, Low DE, Tyrrell GJ, Musser JM (2012) Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus. Am J Pathol 180:1522–1534
Frick IM, Akesson P, Rasmussen M, Schmidtchen A, Bjorck L (2003) SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 278:16561–16566
Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, Zychlinsky A (2007) Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176:231–241
Ginsburg I (1999) Is streptolysin S of group A streptococci a virulence factor? APMIS 107:1051–1059
Gryllos I, Tran-Winkler HJ, Cheng MF, Chung H, Bolcome Rr, Lu W, Lehrer RI, Wessels MR (2008) Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci USA 105:16755–16760
Hertzén E, Johansson L, Wallin R, Schmidt H, Kroll M, Rehn AP, Kotb M, Mörgelin M, Norrby-Teglund A (2010) M1 protein-dependent intracellular trafficking promotes persistence and replication of Streptococcus pyogenes in macrophages. J Innate Immun. 2:534–545
Herwald H, Collin M, Muller-Esterl W, Björck L (1996) Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J Exp Med 184:665–673
Herwald H, Cramer H, Mörgelin M, Russell W, Sollenberg U, Norrby-Teglund A, Flodgaard H, Lindblom L, Björck L (2004) M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116:367–379
Humar D, Datta V, Bast DJ, Beall B, De Azavedo JC, Nizet V (2002) Streptolysin S and necrotising infections produced by group G streptococcus. Lancet 359:124–129
Imöhl M, van der Linden M, Reinert RR, Ritter K (2011) Invasive group A streptococal disease and association with varicella in Germany, 1996–2009. FEMS Immunol Med Microbiol 62:101–109
Johansson L, Linnér A, Sundén-Cullberg J, Haggar A, Herwald H, Loré K, Treutiger C-J, Norrby-Teglund A (2009) Neutrophil-derived hyperresistinemia in severe acute streptococcal infections. J Immunol 183:4047–4054
Johansson L, Thulin P, Low DE, Norrby-Teglund A (2010) Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin Infect Dis 51:58–65
Johansson L, Thulin P, Sendi P, Hertzén E, Linder A, Åkesson P, Low DE, Agerberth B, Norrby-Teglund A (2008) Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect Immun 76:3399–3404
Kahn F, Mörgelin M, Shannon O, Norrby-Teglund A, Herwald H, Olin AI, Björck L (2008) Antibodies against a surface protein of Streptococcus pyogenes promote a pathologic inflammatory response. PLoS Pathog 4(9):e1000149
Kapur V, Maffei JT, Greer RS, Li LL, Adams GJ, Musser JM (1994) Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog 16:443–450
Kapur V, Majesky MW, Li LL, Black RA, Musser JM (1993a) Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 90:7676–7680
Kapur V, Topouzis S, Majesky MW, Li LL, Hamrick MR, Hamill RJ, Patti JM, Musser JM (1993b) A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog 15:327–346
Kaul R, McGeer A, Low DE, Green K, Schwartz B (1997) Ontario group A streptococcal study group. In: Simor E (ed) Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am J Med 103:18–24
Kotb M, Norrby-Teglund A, McGeer A, Dorak MK, Khurshid A, El-Shirbini H, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE (2002) Immunogenetic and molecular basis for the differences in outcomes of invasive group A streptococcal infections. Nat Med 8:1398–1404
Kuo CF, Wu JJ, Lin KY, Tsai PJ, Lee SC, Jin YT, Lei HY, Lin YS (1998) Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun 66:3931–3935
Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C (2008) Strep-EURO Study Group. In: Jasir A (ed) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46:2359–2367
LaPenta D, Rubens C, Chi E, Cleary PP (1994) Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 91:12115–12119
Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A (2000) Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 105:E60
Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schalén C, Henriques-Normark B, Strep-EURO study group, Jasir A (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47:1155–1165
Medina E, Goldmann O, Toppel AW, Chhatwal GS (2003) Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion. J Infect Dis 187:597–603
Metzgar D, Zampolli A (2011) The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification marker. Virulence 2:402–412
Minodier P, Bidet P, Rallu F, Tapiero B, Bingen E, Ovetchkine P (2009) Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children. Pediatr Infect Dis J 28:541–543
Moses AE, Goldberg S, Korenman Z, Ravins M, Hanski E, Shapiro M (2002) Invasive group A streptococcal infections, Israel. Emerg Infect Dis 8:421–426
Musser JM, Shelbourne SA (2009) A decade of molecular pathogenomic analysis of group A streptococcus. J Clin Invest 119:2455–2463
Nelson DC, Garbe J, Collin M (2011) Cysteine proteinase SpeB from Streptococcus pyogenes—a potent modifier of immunologically important host and bacterial proteins. Biol Chem 392:1077–1088
Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454–457
Nooh MM, Nookala S, Kansal R, Kotb M (2011) Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: implications for customized patient care. J Immunol. 186:3156–3163
Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M (2000) Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 30:3247–3255
Norrby-Teglund A, Lustig R, Kotb M (1997) Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates. Infect Immun 65:5209–5215
Norrby-Teglund A, Pauksens K, Holm SE, Norgren M (1994) Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect Dis 170:585–591
Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, Low DE (2001) Evidence for superantigen involvement in severe group A streptococcal tissue infection. J Infect Dis 186:853–860
Nuwayhid ZB, Aronoff DM, Mulla ZD (2007) Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis. Ann Epidemiol 17:878–881
Nyberg P, Rasmussen M, Björck L (2004) ∝2-Macroglobulin-proteinase complexes protects Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem 279:52820–52823
Olsen RJ, Musser JM (2010) Molecular pathogenesis of necrotizing fasciitis. Ann Rev Pathol Mech Dis 5:1–31
Olsen RJ, Sitkiewicz I, Ayeras AA, Gonulal VE, Cantu C, Beres SB, Green NM, Lei B, Humbird T, Greaver J, Chang E, Ragasa WP, Montgomery CA, Cartwright JJ, McGeer A, Low DE, Whitney AR, Cagle PT, Blasdel TL, DeLeo FR, Musser JM (2010) Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci USA 107:888–893
Osterlund A, Popa R, Nikkila T, Scheynius A, Engstrand L (1997) Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 107:640–647
Patel RA, Binns HJ, Shulman ST (2004) Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. J Pediatr 144:68–74
Påhlman LI, Möreglin M, Eckert J, Johansson L, Russell W, Riesbeck K, Soehnlein O, Lindbom L, Norrby-Teglund A, Schumann RR, Björck L, Herwald H (2006) Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 177:1221–1228
Påhlman LI, Olin AI, Darenberg J, Mörgelin M, Kotb M, Herwald H, Norrby-Teglund A (2007) Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol 10:404–414
Rasmussen M, Bjorck L (2002) Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol 43:537–544
Rasmussen M, Muller HP, Bjorck L (1999) Protein GRAB of streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J Biol Chem 28:15336–15344
Rohde M, Muller E, Chhatwal GS, Talay SR (2003) Host cell caveolae act as an entry-port for group A streptococci. Cell Microbiol 5:323–342
Schmidtchen A, Frick IM, Andersson E, Tapper H, Bjorck L (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46:157–168
Smeesters PR, McMillan DJ, Sriprakash KS (2010) The streptococcal M protein: a highly versatile molecule. Trends Microbiol 18:275–282
Soehnlein O, Oehmcke S, Ma X, Rothfuchs AG, Frithiof R, van Rooijen N, Mörgelin M, Herwald H, Lindbom L (2008) Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur Respir J 32:405–412
Staali L, Bauer S, Mörgelin M, Björck L, Tapper H (2006) Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes. Cell Microbiol 8:690–703
Staali L, Morgelin M, Bjorck L, Tapper H (2003) Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils. Cell Microbiol 5:253–265
Stevens DL (1992) Invasive group A streptococcus infections. Clin Infect Dis 14:2–13
Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321:1–7
Svensson MD, Scaramuzzino DA, Sjobring U, Olsen A, Frank C, Bessen DE (2000) Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol Microbiol 38:242–253
Thulin P, Johansson L, Low DE, Gan BS, Kotb M, McGeer A, Norrby-Teglund A (2006) Viable group A streptococci in macrophages during acute soft tissue infections. PLoS Med 3:0371–0379
Tognetti L, Martinelli C, Hercogiva J, Lotti T, Leoncini F, Moretti S (2012) Bacterial skin and soft tissue infections: review of the epidemiology, microbioogy, aetiopåathogenesis and treatment. J Eur Acad Dermatol Venerol 26:931–941
Tran-Winkler HJ, Love JF, Gryllos I, Wessels MR (2011) Signal transduction through CsrRS confers an invasive phenotype in group A Streptococcus. PLoS Pathog 7:e1002361
Tyrrell GJ, Lovgren M, St Jean T, Hoang L, Patrick DM, Horsman G, Van Caeseele P, Sieswerda LE, McGeer A, Laurence RA, Bourgault AM, Low DE (2010) Epidemic of group A Streptococcus M/emm59 causing invasive disease in Canada. Clin Infect Dis 51:1290–1297
Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, McArthur JD, Dinkla K, Aziz RK, Kansal RG, Simpson AJ, Buchanan JT, Chhatwal GS, Kotb M, Nizet V (2007) DNase SdaI provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med 13:981–985
Wannamaker LW (1970) Differences between streptococcal infections of the throat and of the skin. N Engl J Med 282:23–31
Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO (2003) Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85-A:1454–1460
Acknowledgments
Financial support: The Swedish Research Council (ANT: 12610; LJ: 522-2010-2868), Torsten and Ragnar Söderberg’s Foundation (ANT), ESCMID (LJ), Karolinska University Hospital and the Karolinska Institutet.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Johansson, L., Norrby-Teglund, A. (2012). Immunopathogenesis of Streptococcal Deep Tissue Infections. In: Chhatwal, G. (eds) Host-Pathogen Interactions in Streptococcal Diseases. Current Topics in Microbiology and Immunology, vol 368. Springer, Berlin, Heidelberg. https://doi.org/10.1007/82_2012_282
Download citation
DOI: https://doi.org/10.1007/82_2012_282
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36339-9
Online ISBN: 978-3-642-36340-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)